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ABSTRACT
The Relationship Between Vascular Endothelial Function and
Peak Exercise Blood Flow
Brady Edward Hanson
Department of Exercise Sciences, BYU
Master of Science
Purpose The vascular endothelium is an influential contributor to vasodilation at rest, yet
its role during peak exercise is relatively unknown. The purpose of this study is to determine if
exercise leg blood flow during dynamic submaximal and maximal exercise is related to resting
vascular endothelial function. Methods Nineteen subjects (aged 23 ± 0.57 yr) completed
multiple assessments of vascular endothelial function including passive leg movement (PLM),
rapid onset vasodilation, (ROV) and flow-mediated dilation (FMD). Peak muscle blood flow was
assessed during single leg knee extension (KE) exercise. Doppler ultrasound of the femoral
artery was utilized to assess muscle blood flow. Results Peak exercise blood flow was linearly
related with microvascular endothelial function determined by PLM (P < 0.001) and ROV (P <
0.001). Normalizing muscle blood flow for quadriceps mass did not change this significant
association. Individuals with high vascular endothelial function had greater muscle blood flow
during KE compared to those with low endothelial function (P = 0.05). Post hoc analysis
indicated a significant difference in blood flow between high and low endothelial function
groups at 20 W, 30 W, and peak flow (P = 0.042, 0.048, 0.001, respectively). Conclusion Peak
muscle blood flow during dynamic exercise is correlated with vascular endothelial function, as
measured by PLM and ROV, accounting for between 30 to 50% of the variance in this
relationship. These data support the hypothesis that endothelial function significantly contributes
to the peak blood flow response during dynamic exercise.
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INTRODUCTION
The ability of the body to increase blood flow to skeletal muscle in response to a stimulus
influences one’s ability to perform and sustain exercise (1). While rates of muscle blood flow are
heavily influenced by the rate of work being performed, there is considerable subject-to-subject
variability in the rate of muscle blood flow observed at a given work rate. For example, Garten et
al. (2) observed a range of quadriceps muscle blood flow of about 1,500 ml·min-1 when healthy
young males performed 25 W of single leg knee extension exercise (KE). Moreover, peak blood
flow also varies with fitness level. Blood flow in endurance-trained individuals, for example, has
been shown to reach 1,000–2,000 ml·min-1 greater than age-matched untrained individuals (3).
The flow of fluid (blood), as described by Poiseuille’s law 𝑄𝑄̇ = (∆Pπr4)/8Ln, is heavily

influenced by change in blood pressure across the muscle (∆P) and the radius (r) of vascular

network (i.e., cross-sectional area of vascular network). The ability of the muscle to increase
blood flow during exercise is influenced by multiple factors including vascular density, limb
size, sympathetic tone, and vasodilatory capabilities which would affect the total change in
radius or cross–sectional area in the vascular bed of the exercising muscle (4–6). As radius is
raised to the fourth power, the vasodilatory capacity is of great importance in achievement of
higher blood flow.
One of the most influential contributors to vasodilation is the vascular endothelium,
which releases vasodilator substances, such as nitric oxide (NO), prostaglandins, and
hyperpolarizing factors (7–10). Enhancements to the endothelium’s ability to produce these
substances increase the vasodilatory capacity, leading to increased blood flow to meet O2
demand (11,12). Given the importance of muscle blood flow, it seems probable that enhanced
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endothelial function may contribute to greater peak blood flow and O2 delivery during exercise
(3).
Vascular endothelial function is clearly a major contributor to the regulation of blood
flow at rest, but its role during exercise remains unclear (13,14). For example, Frandsen et al.
(15) observed no change in blood flow during KE exercise after inhibiting NO synthase,
indicating that NO is not essential for exercise blood flow. Nevertheless, they did observe a
~20% reduction in vascular conductance (expressed as blood flow/mean arterial pressure, i.e., an
index of vasodilation) during KE when NO synthase was inhibited. From subsequent studies
which simultaneously inhibited multiple endothelium-derived vasodilators, a redundant
mechanism theory has arisen, indicating that additional vasodilatory mechanisms may
compensate when the function of another endothelium-dependent dilator is attenuated (8,16). For
example, Mortensen et al. (8) demonstrated that blood flow during light intensity KE was
unchanged after the prostaglandins dilator system was inhibited, but subsequently decreased
when NO and prostaglandins production were inhibited simultaneously. In contrast, animal
studies have found that blood flow and vascular conductance are attenuated during exercise with
inhibition of NO (17,18).
Many different methods have been used to assess vascular endothelial function. The
flow–mediated dilation (FMD) assessment of endothelial function, based on blood flow
regulation in conduit vessels, has become common place in laboratories (19,20). The more
simple and practical methods of passive leg movement (PLM) (21) and rapid onset vasodilation
(ROV) (22,23), both of which are dependent on NO bioavailability (14,24), are emerging as
insightful endothelial function assessments. The PLM and ROV assessments both measure the
initial hemodynamic response to exercise. Based primarily on the dilation of microvascular
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rather than the conduit arteries (14,21), PLM and ROV may provide a unique understanding of
what drives the increases in leg blood flow during exercise.
While vascular endothelial function has been shown to be greater in individuals who are
active (25), the role that vascular endothelial function plays in exercise leg blood flow, including
peak exercise blood flow, has not thoroughly been documented. With the endothelium playing an
important role in vasodilation, the purpose of this study is to determine if leg blood flow during
maximal and submaximal KE exercise in young healthy adults is related to vascular endothelial
function assessed by FMD, PLM, and ROV at rest.
METHODS
Subjects
Twenty–one young, healthy subjects were recruited for this study, of which two subjects
were disqualified due to the inability to perform knee extension exercise. Thus, 19 subjects (12
male, 7 female, 18–30 years old) completed the present study. All subjects were healthy,
nonobese, nonsmokers, and free from medications that would affect their hemodynamic
responses to exercise (21). Females participating in the study had all data collected within the
first seven days of the menstrual cycle (26,27). Subjects completed a prescreening questionnaire
and reviewed the informed consent form with the primary investigator prior to providing written
and informed consent. This study was approved by the Institutional Review Board (IRB) at
Brigham Young University (BYU), and performed in accordance with the Declaration of
Helsinki.
Procedures
Subjects reported to the laboratory on two occasions, well rested, having fasted for 4
hours, and having refrained from exercise and consumption of alcohol or caffeine for ~24 hours

3

(19,21). Each visit was separated by a minimum of 24 hours. All data collection and exercise
were completed on the subject’s right leg, regardless of leg dominance.
Prior to the main experiment, body measurements including height (cm) and weight (kg)
were measured, and body mass index (BMI, kg·m-2) was calculated. Additionally, quadriceps
muscle volume was measured noninvasively, as described by Layec et al. (28), with a
combination of limb circumference measurements and skin fold thickness measurements. This
method strongly correlated to measures of thigh and quadriceps muscle volume assessed by
MRI. Muscle volume measurements were then converted to quadriceps muscle mass by
assuming a muscle density of 1.49 kg·L-1 (29).
Assessment of Single Leg Maximum Voluntary Contraction
Maximum voluntary contraction (MVC) for weighted knee extension on the right leg was
completed on a cable weighted knee extension machine. Subjects completed a warm-up set of 10
repetitions at 40–60% of estimated MVC. Following a period of 2 min rest, 5 repetitions at 60–
80% of estimated MVC was completed. Performance of 3–4 more attempts with increasing
weight were completed until an MVC was achieved. The greatest amount of weight the subject
was able to lift with full knee extension was recorded as the MVC.
Assessment of Endothelial Function
Passive Leg Movement (PLM): Endothelial function was assessed via PLM, according to
recently published procedures (11,21). Specifically, subjects were seated in an upright position
with knees fully extended (180o). Researchers controlled the movement of the leg back and forth
from the extended position of the knee (180o) to the flexed position (90o), at a rate of 60 knee
extensions per min, while the subjects stayed relaxed with no voluntary muscle activation (30).
Cadence of the knee flexion and extension was established using a metronome. A knee brace set
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to allow 90o of knee flexion/extension was worn throughout the PLM assessment. This procedure
was completed three times with a 10–15-min period of rest between each attempt. Femoral artery
blood flow and mean arterial pressure (MAP) were measured throughout the assessment utilizing
Doppler ultrasound and finger photoplethysmography, respectively. Blood flow data were
subsequently analyzed second-by-second and a 3-s rolling average was applied to smooth the
data. The peak blood flow and the area under the curve (total blood flow) were identified for
each of the three 1-min trials and then averaged together (21). The data presented in this
manuscript are the average of the three trials. A more detailed description of the ultrasound
measurements is provided below.
Rapid Onset Vasodilation (ROV): After completion of the PLM assessment, subjects
rested 10–15 min before completing the ROV assessments of vascular endothelial function (22).
Subjects were seated in an upright position with legs hanging over the end of the seat of a cableweighted machine with knees in a flexed position. Following 1 min of baseline data collections,
subjects extended the knee to ~180o and then back to 90o with no engagement of knee flexor or
extensor muscles during the knee flexion phase (e.g., full extension and then relax). All subjects
completed two trials at an absolute work set at 60 Newton meters (Nm), each separated by 2-min
rest (22,31). As work is the product of mass, displacement distance, and gravity, the mass each
subject lifted was determined based upon their displacement distance, measured during the MVC
protocol, to ensure the performance of 60 Nm during each extension. Femoral blood flow and
MAP were gathered for 1-min baseline prior to contraction, immediately followed by collection
during contraction and 1-min recovery utilizing Doppler ultrasound and finger
photoplethysmography. Data were subsequently analyzed second-by-second and a 3-s rolling
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average was applied to smooth the data. The peak blood flow and the area under the curve were
identified for each 1-min trial and then averaged together.
Flow Mediated Dilation (FMD): On a different day, separated by at least 24 hours,
subjects reported to the lab well rested and in a fasted state (~4 hours) to have endothelial
function assessed via FMD. Procedures for FMD were performed in accordance with current
recommendations (20) and specifically completed on the superficial femoral artery (32). While
lying in the supine position, a 9 cm blood pressure cuff (D. E. Hokanson Inc., Bellevue, WA,
USA) was placed on the upper leg just proximal to the knee cap. Baseline measurements
(diameter and blood flow) were gathered for 1 min as the ultrasound probe was placed over the
superficial femoral artery approximately 10 cm proximal to the cuff. The cuff was then inflated
for 5 min at suprasystolic pressures (~250 mmHg). Prior to the release of the cuff, 30 s of blood
flow data was collected, immediately followed by 2 min of data collection after the release of the
cuff pressure. Diameter of the superficial femoral artery was measured for FMD assessment
during the last 30 s of occlusion and 2 min following the release of the cuff pressure. Diameter
was analyzed frame-by-frame by automated edge detection software (Quipu srl., Pisa, Italy) and
averaged into 1-s bins corresponding with 1-s average velocities. Superficial femoral artery
blood velocity was assessed with a Doppler frequency of 5 MHz operated in the high-pulsed
repetition frequency mode. A 3-s rolling average was applied to smooth diameter and velocity
data. FMD measurements were expressed as a percent change in diameter and calculated with
the equation:
𝐹𝐹𝐹𝐹𝐹𝐹 (%) =

(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷 − 𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵 𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷)
𝑥𝑥 100
𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵 𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷

while peak flow following the release of the cuff (i.e., FMDFlowPeak) was identified as the greatest
1-s average of flow achieved following cuff release (20).
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Knee Extension Assessment of Blood Flow
Knee Extension Familiarization: Following these assessments, subjects were given time
to familiarize themselves with dynamic knee extension exercise, which would ultimately be used
to determine peak exercise blood flow (i.e., KE FlowPeak). During this familiarization and
subsequent knee extension tests, subjects were seated in an upright position, with the right leg
attached to the knee extension ergometer (a modified Monarch cycle ergometer), as first
described by Andersen et al. in 1985 (33). During this exercise subjects were instructed to
participate only in active knee extension exercise, with no active knee flexion, thus isolating the
majority of the work to the quadriceps femoris of the thigh. With visible feedback of cadence,
subjects were instructed to extend the knee at a rate of 60 rpm for the duration of the exercise.
Knee Extension Maximum Work Rate Assessment: After familiarization, a graded
exercise test to determine maximum knee extension work rate (WRmax) for dynamic single leg
knee extension on the right leg was completed. Starting at 10 W, subjects began extending the
leg at a rate of 60 rpm for a warm-up of 3 min. Following this warm-up, work rate increased by
5–10 W (depending upon subjects’ perceived effort) every minute thereafter until the subject
could no longer maintain a frequency of 60 rpm despite verbal encouragement. The highest
power output completed for 1 min was identified as WRmax.
Femoral Artery Blood Flow During Dynamic Knee Extension: On a separate day, while
well rested, subjects completed 3-min bouts of six exercise intensities of single leg KE exercise
(10 W, 20 W, 30 W, and 75%, 90% and 100% predetermined WRmax). If subjects were able to
complete 100% WRmax, following ~5 min of rest, work rate (WR) was increased to 110% of the
predetermined WRmax and so on until failure. The first three work rates (10–30 W) were
completed sequentially, totaling 9 min of exercise. A period of ~5 min of active recovery, at a
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low intensity and rpm, followed the exercise. The last three work rates (75–100% WRmax) were
each completed with ~5 min of active recovery between each bout. All data, including blood
flow and MAP for all work rates, were recorded during the final 1 min of each 3-min period, as
described in Doppler Ultrasound and Finger Photoplethysmography, respectively.
Blood Flow and Vascular Conductance Measurements
Doppler Ultrasound: Femoral artery blood flow was measured second-by-second for 60 s
for PLM, ROV, and FMD assessments, and 12-s averages were measured during KE for the last
1 min of each workload. Leg blood flow during PLM, ROV, and KE was assessed utilizing
Doppler ultrasound of the common femoral artery, proximal to the exercising muscles.
Specifically, measurements of common femoral artery blood velocity and artery diameter, 2–3
cm proximal to the superficial/deep bifurcation, were taken using a Logiq E ultrasound Doppler
system in duplex mode (General Electric Medical Systems, Milwaukee, WI, USA) equipped
with a linear array transducer function at a B-mode frequency of 9 MHz and a Doppler frequency
of 5 MHz. Blood velocity was assessed with an insonation angle of no more than 60°, while the
sample size was maximized and centered according to vessel size and position in real time.
Ultimately, femoral blood flow (ml·min-1) was calculated using the equation:
Femoral blood flow = [(mean blood velocity) × (𝜋𝜋 × (vessel radius2 )) x 60s]

Where mean blood velocity is expressed in cm·s-1 and radius is expressed in cm.

Finger Photoplethysmography: Blood pressure was measured continuously with a finger
photoplethysmography system (CNAP, CNSystems, Graz, Austria) using the vascular unloading
technique of Peňáz (34). MAP was calculated as the pressure-time integral of the continuous
finger blood pressure measurement (21).
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Statistical Analysis
All data are expressed as the mean ± SE. Repeated-measures ANOVA, followed by a
Tukey’s post hoc test, was used to identify the effect of KE WR on blood flow. Correlations
between relevant variables were evaluated using Pearson correlation coefficients, with alpha set
at P < 0.05 a priori. A stepwise linear regression for KEFlowPeak was completed using
PLMFlowPeak, ROVFlowPeak,

FMD, quadriceps mass, and KE WRmax as independent variables.

Repeated measures analysis of variance (ANOVA) was used to compare blood flow across KE
WR. A mixed-model ANOVA with repeated measures for work rate and two independent groups
was used to test differences in KEFlowPeak between individuals with high and low endothelial
function. When significance was detected, Tukey’s post hoc identified between-group
differences. All statistical analyses were completed using SPSS version 21 (SPSS Inc., Chicago,
IL, USA).
RESULTS
Nineteen young (age 23 ± 0.57 yr), healthy individuals (12 male, 7 female) completed the
present study. See Table 1 for subject characteristics.
Blood Flow Response to Knee Extension Exercise
As shown in Figure 1, there was a main effect of work rate on blood flow during knee
extension exercise (KE) within subjects. Blood flow increased with each increase in WR (P <
0.001) until WRmax, which did not significantly differ from 90% WRmax to 100% WRmax (P =
0.17). Peak flow was identified as the highest blood flow achieved, regardless of WR. Blood
flow increases in a linear manner from rest (380.1 ± 27.51 ml·min-1) to peak exercise (52.6 ±
4.08 W, 4310.47 ± 217.88 ml·min-1) (Table 1).

9

Relationship Between Peak Exercise Blood Flow and Vascular Endothelial Function
As illustrated in Figure 2, among the three assessments of vascular endothelial function
there was a significant positive, linear correlation between peak blood flow elicited from KE
(KEFlowPeak) and peak blood flow from both PLM (PLMFlowPeak) (r = 0.77, P = 0.001; Figure 2A)
and ROV (ROVFlowPeak) (r = 0.69, P = 0.001; Figure 2B). The PLMFlowPeak and ROVFlowPeak were
1434.6 ± 102.23 ml·min-1 and 1951.45 ± 132.1 ml·min-1, respectively (Table 1). FMD had no
significant correlation with KEFlowPeak (r = -0.02, P = 0.86; Figure 2C), with an average percent
dilation increase across all subjects of 6.15 ± 0.64 % (Table 1). Although no significant
correlation was found between endothelial function and blood flow at 10 W, there was
significance at 20 W with ROVFlowPeak (P = 0.04) and PLMFlowPeak trending towards significance
(P = 0.06).
When normalizing for quadriceps mass, the correlation between PLMFlowPeak and
KEFlowPeak

remained significant (r = 0.62, P = 0.001; Figure 3A), as well as the correlation

between ROVFlowPeak and KEFlowPeak (r = 0.51, P = 0.05; Figure 3B). When normalized for
quadriceps mass, FMD exhibited a significant positive, linear correlation with KEFlowPeak (r =
0.45, P = 0.05; Figure 3C). Additional correlations of interest are listed in Tables 2 and 3.
At an absolute work rate of 30 W, there was a significant positive, linear correlation
between femoral artery blood flow at 30 W (KEFlow 30) and PLMFlowPeak (r = 0.47, P = 0.04), and
ROVFlowPeak

(r = 0.67, P = 0.03) (Table 2). FMD showed no significant correlation with KEFlow30

(r = -0.12, P = 0.62). Normalizing for quadriceps mass (Table 3), the correlation between
PLMFlowPeak

and KEFlow30 was no longer significant (r = 0.32, P = 0.18), likewise, the correlation

between ROVFlowPeak and KEFlow30 was weakened (r = 0.38, P = 0.11). In contrast, FMD
exhibited a significant positive, linear correlation with KEFlow30 (r = 0.58, P = 0.01). No
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significant correlation was found between endothelial function and blood flow at 10 W (all P >
0.05). At 20 W there was a significant relationship between ROVFlowPeak (r = 0.47, P = 0.04) and
KEFlow,

and a tendency for a relationship between and PLMFlowPeak and KEFlow (r = 0.43, P =

0.07).
Relationship Between Peak Vascular Conductance and Vascular Endothelial Function
Among the three assessments of vascular function, there was a significant positive, linear
correlation between peak vascular conductance elicited from KE exercise (KEConductancePeak)
and peak vascular conductance from PLM (PLMConductancePeak) (r = 0.51, P = 0.04) (Table 2).
No correlation was found with ROV (ROVConductancePeak) (r = -0.15, P = 0.55). FMD also had
no significant association with KEConductancePeak (r = -0.08, P = 0.74; Figure 2C). All other
important correlations are listed in Table 2.
Correlation Between Blood Flow During KE and Vascular Endothelial Function when
Controlling for Quadriceps Mass and Power Output
Partial correlations, controlling for quadriceps mass and power output during KE
exercise, were performed to determine if the relationship between endothelial function and KE
blood flow exists independently of these factors. Controlling for quadriceps mass, KEFlowPeak
was found to still have a significant correlation with PLMFlowPeak (r = 0.64, P = 0.004),
PLMFlowAUC

(r = 0.62, P = 0.007), and ROVFlowPeak (r = 0.57, P = 0.01) (Table 4A). Controlling

for work rate performed during maximal KE, KEFlowPeak was found to still have a significant
correlation with PLMFlowPeak (r = 0.70, P = 0.001), PLMFlowAUC (r = 0.63, P = 0.005), and
ROVFlowPeak

(r = 0.61, P = 0.007) (Table 4B). Additional partial correlations of interest are listed

in Tables 4A and 4B.
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Stepwise Linear Regression
A stepwise linear regression was completed for the dependent variable KEFlowPeak, with
specific predictor variables: PLMFlowPeak, ROVFlowPeak, FMD, quadriceps mass, and KE WRmax.
The strongest predictor was identified as PLMFlowPeak, with the equation Flow = 1981.6 +
1.639(PLMFlowPeak); (r2 = 0.592 P = 0.001), with flow being expressed in ml·min-1. KE WRmax
was the only other predictor variable that significantly added to the prediction equation (r2 =
0.749, P < 0.001), with the final equation being: Flow = 1367.7 + 1.181(PLMFlowPeak) + 24(KE
WRmax), with an r2 change of 0.157 (P = 0.006).
Blood Flow During Knee Extension in Individuals with Low and High Endothelial Function
After completing the study, the effect of endothelial function, assessed by PLMFlowPeak, on
KEFlow

was examined by splitting the data into two groups, a low endothelial function group

(bottom 8 subjects) and high endothelial function group (top 8 subjects), based upon absolute
PLMFlowPeak

and expressed in ml·min-1. The remaining 3 subjects’ data was unused as to create a

distinct separation between the two response groups. Table 5A shows the hyperemic response to
increasing WR during KE for the two groups. There was a significant main effect of work rate
within subjects, such that increasing work rate was associated with increased blood flow (P <
0.001). There was also a significant main effect of group such that the high endothelial function
group had greater blood flow overall compared to the low endothelial function group (P = 0.05).
Post hoc analysis indicated a significant difference in blood flow between groups at 20 W, 30 W,
and peak flow (P = 0.042, 0.048, 0.001, respectively). Overall, the low endothelial function
group had smaller quadriceps mass and contained a greater proportion of females to males
compared to the high endothelial function group. Subject characteristics for each group are listed
in Table 5A.
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In Table 5B, subjects were divided into high and low endothelial function groups based
upon PLMFlowPeak, normalized for quadriceps mass and expressed as ml·min-1·kg-1. Note that
these groups are not made up of the same subjects as in Table 5A. When normalizing for
quadriceps mass, a significant main effect of endothelial function group was observed (P = 0.05),
such that those with a higher PLM response achieved significantly higher blood flow per kg of
quadriceps mass at any given work rate. Tukey’s least significant difference post hoc indicated a
significant difference in blood flow per kg of quadriceps mass between groups at 30 W and peak
flow (P = 0.025, and 0.008, respectively). Subject characteristics for each of these groups are
listed in Table 5B.
DISCUSSION
In the present study, the use of multiple assessments of vascular endothelial function
(PLM, ROV, FMD) and a valid measurement of peak leg blood flow (single leg knee extension;
Figure 1) (35) were used to evaluate the relationship between endothelial function and exercise
blood flow. There were two novel findings demonstrated in this study: 1) KEFlowPeak was
significantly correlated with assessments of vascular endothelial function, particularly those
assessing microvascular function and 2) that individuals with high vascular endothelial function
demonstrated a greater KEFlow at submaximal and maximal KE work rates. These findings
highlight the important contribution of endothelial function to peak muscle blood flow during
dynamic KE exercise.
Relationship Between Endothelium-Dependent Dilation and Peak Exercise Flow
Maximum blood flow during exercise is the product of a number of components (4).
Though there are a number of factors involved in the control of peak exercise blood flow, this
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study explored three important factors: vasodilatory capability, muscle mass, and perfusion
pressure and their relationship during peak exercise.
Vasodilatory Capability: Microvascular Endothelial Function
The hyperemic response to the PLM is highly related to the function of the vascular
endothelium (14,32,36) especially that of the microvasculature (21). Figure 2A shows that
greater PLMFlowPeak was associated with a higher KEFlowPeak (P < 0.001). The hyperemic
response to PLM is highly dependent on NO bioavailability (~80%) (14,37,38). As such, the
close association between PLMFlowPeak and KEFlowPeak suggests that endothelial function is
involved in this relationship. The hemodynamic response to ROV has a similar endothelial
component to that of PLM but also includes mechanical and adrenergic factors (23). The ROV
assessment is also a good indicator of NO-dependent vasodilation (23,24), and, much like PLM,
is reflective of microvascular function. In agreement with the PLM response, Figure 2B shows
that greater ROVFlowPeak elicited higher KEFlowPeak (P < 0.001). Mechanical factors such as shear
stress and stretch are the likely cause of NO production. As there are higher rates of both shear
stress and stretch during peak exercise, it is possible that the endothelial-derived production of
vasodilators increases during these times, subsequently leading to greater vasodilation and
KEFlowPeak.

The relationship between microvascular function and exercise blood flow is further
supported by the significant relationship between KEFLOWPEAK and the reactive hyperemia
response to cuff occlusion (FMDFLOWPEAK), which is reflective of the microvascular function in
an entirely different vascular bed (calf) than was exercised during knee extension (quadriceps)
(39). Thus, the endothelial function of the microvasculature appears to be strongly related to the
peak exercise flow.
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Vasodilatory Capability: Conduit Artery Endothelial Function
In contrast to the assessment of the microvascular endothelial function with PLM and
ROV, the FMD assessment is indicative of conduit artery function (40,41). These measurements
in conduit arteries (i.e., brachial or superficial femoral) have long been established as an
assessment of endothelial-derived NO bioavailability (20,42). Recent findings suggest, however,
that FMD should be viewed more as endothelium-dependent vasodilation and not necessarily
NO-dependent vasodilation (43,44), separating itself from PLM and ROV. In the present study,
contrary to PLM and ROV, no correlation was found between FMD and KEFlowPeak (Figure 2C).
The absence of a correlation may be due to many factors including the effects of muscle mass,
artery size, and sympathetic activity on FMD (45). One of these potential reasons is the strong
inverse relationship between artery or leg size and FMD (46). Green et al. (47) suggest that
individuals with increased lumen size and wall thickness, which may be more common in those
with larger legs, tend to present with lower FMD response. The increased size of the artery
means there is less need for more dilation in the presence of an ischemic stimulus. It is important
to note that in this scenario, while the FMD was assessed on an artery in the thigh (superficial
femoral), the artery is not a major supplier of the muscle active during KE (i.e., quadriceps
femoris). Thus, the assessment of FMD in this study was not as linked to the quadriceps utilized
during KE as PLM and ROV were, which mostly assess the vascular function in the quadriceps.
This may also be part of the reason for a lack of relationship between FMD and KEFlowPeak.
Relationship Between Muscle Mass and Peak Exercise Flow
The size of the vascular network, comprised of the density of arterioles and capillaries as
well as leg muscle size, has a large bearing on the hyperemic response to an exercise stimulus
(48). In an attempt to clarify the involvement of the endothelium during exercise, data were
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analyzed both mathematically, normalizing for quadriceps mass (i.e., dividing by quadriceps
mass, Figure 3), and statistically, controlling for quadriceps mass (Table 3 and 4A). As
illustrated in Figure 3, the correlation between PLMFlowPeak and KEFlowPeak remains significant
(Figure 3A, P < 0.001), and the correlation between ROVFlowPeak and KEFlowPeak also remains
significant (Figure 3B, P < 0.05). Notably, when normalizing for quadriceps muscle mass, the
relationship between FMD and KEFlowPeak becomes significant (Figure 3C). Moreover, when
statistically controlling for quadriceps mass (i.e., partial correlation), multiple indices of
endothelial function, including PLMFlowPeak, are still related to KEFlowPeak (Table 4A). These
findings indicate that KEFlowPeak is related to these assessments of vascular endothelial function
independent of leg mass, further supporting the relevance of the endothelium in KEFlowPeak (2).
An additional component to the vascular network is the actual density of the network, or
the number of arterioles or capillaries per unit of volume within the muscle. Indeed, blood flow
increases as the number of potential pathways to accept blood increases (i.e., increasing the total
cross-sectional area of the vascular network). Exercise training has been shown to greatly
increase vascular density even among muscle groups with lower mass (49). While Robbins et al.
(48) reported no relationship between capillary density and peak reactive hyperemia (i.e.,
FMDFlowPeak),

it is possible that part of the relationship between our indices of vascular function

and peak exercise flow could be mediated by differences in vascular/capillary density. Without
measurements to quantify vascular density in this study, it is not possible to confirm nor rule out
the role of vascular density in the relationships observed in this study. As these measurements
were beyond the scope of this study, future investigations should seek to include these measures.
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Relationship Between Perfusion Pressure and Peak Exercise Flow
As mentioned, in addition to changes in total cross-sectional area of the vascular bed,
blood flow to a muscle is also influenced by perfusion pressure. Notably, MAP did not exhibit a
significant relationship with KEFLOWPEAK (Figure 2D), supporting the notion that differences in
blood flow are more related to vasodilatory capacity than to differences in perfusion pressure.
Summary
To determine which of the above factors exhibited a significant independent relationship
with KEFlowPeak, a stepwise linear regression analysis was performed with the various
assessments of endothelial function, quadriceps mass, work rate during peak flow, and MAP
during peak flow as predictor variables. Notably, endothelial function, assessed as PLMFlowPeak,
and the work rate during peak flow were the only two significant independent predictors of
KEFlowPeak,

with PLMFlowPeak being the most predictive and significant of the two. Thus,

endothelial function, assessed by PLM, is even more predictive of peak flow during exercise than
the work rate of the exercise, the size of the active muscle, and the perfusion pressure.
Comparison of High and Low PLM Responders to Blood Flow
To gain greater understanding of the role of the endothelium during exercise blood flow,
we compared the hyperemic response to exercise of individuals with low PLMFlowPeak response
(L-PLM) to individuals with higher PLMFlowPeak response (H-PLM). Individuals in the L-PLM
group were classified as the lowest 8 subjects based on PLMFlowPeak, and the H-PLM were
classified as the highest 8. As illustrated in Figure 4A, the H-PLM group exhibited greater
KEFlow

than the L-PLM group, with values at 20 W, 30 W and WRmax significantly differing.

These findings indicate that endothelial function is not only related to peak flow, but also to flow
at submaximal work rates.
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Mass Specific
At this point it is important to note that the H-PLM and L-PLM groups pictured in Figure
4A differed in more than just endothelial function, with quadriceps muscle mass and sex being
among the more important differences. Thus, a second comparison was made by creating two
groups comprised of individuals who exhibited high or low PLMFlowPeak per kg of quadriceps
mass. Prior to quadriceps mass normalization (Figure 4A), sex distribution was 3 males and 5
females in the L-PLM group, and 8 males in the H-PLM group. Once quadriceps mass was
normalized, sex distribution was 5 males and 3 females in the L-PLM group, and 6 males and 2
females in the H-PLM group. This helped further isolate endothelial-specific function
independent of other influences. As illustrated in Figure 4B, there remained a significant effect
of endothelial function between groups, with KEFlow significantly differing at 30 W and peak
flow.
At first glance, the relationship between vascular endothelial function, assessed by PLM,
and peak exercise blood flow may seem to disagree with previous studies showing no effect of
NO synthase inhibition of KEFlow. It is important to recognize that differences in exercise
intensity separate the current study and several animal-based studies, which implicate a role of
NO in exercise blood flow (18,50), with most human NO synthase inhibition studies (8,15).
Human studies suggesting that NO-dependent dilation was not essential during exercise were
completed at low intensities (20–30 W) (8,15). In contrast, the animal studies that indicated NO
inhibition did decrease blood flow were completed at a maximal effort (17,18). Later human
studies, utilizing a different mode of exercise (handgrip), found that NO synthase inhibition
reduced blood flow by ~20% at high intensities, while having little effect at low intensities (51–
53). The present study agrees with the importance of exercise intensity. Results found no
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relationship between endothelial function and blood flow at low intensities (10–20 W) but found
a significant correlation at high intensities (30+ W). Another reason for differing outcomes
between studies may be due to limitations in the amount of drugs (i.e., the NO inhibitor NGmono-methyl-L-arginine (L-NMMA)) that can safely be administered to humans. A dose within
a safe and acceptable range for humans may not be potent enough to elicit a decrease in blood
flow, as seen in animals with much greater doses (15,17).
The importance of NO-dependent vasodilation is further supported in studies showing
that NO supplementation (via nitrate and nitrite) significantly improved exercise blood flow (54–
56). This evidence indicates that vascular endothelial function (NO-dependent dilation) is indeed
heavily involved in exercise blood flow. The present study emphasizes the relationship between
vascular endothelial function and peak exercise blood flow, suggesting that peak flow may
indeed be influenced by NO-dependent dilation, as PLM and ROV assessments of vascular
endothelial function are NO-dependent (24,37).
Experimental Considerations
There are some experimental considerations of note in the current study. First, though
PLM and ROV are primarily considered assessments of quadriceps muscle blood flow, it is
acknowledged that there is some contribution from other muscles in the leg. Second, there may
be variation in the ROV single-leg contraction between subjects such that the speed, force of
contraction, and anticipation of the kick may all influence quadriceps blood flow measurements.
To minimize this effect, subjects were given time to practice the ROV procedure, one kick at a
rate of about 90°/s (one extension over the course of 1 s). In the assessment of KEFlowPeak it was
assumed that only knee extensor muscles were used. However, other muscle groups such as core
stabilizers or knee flexor muscles may have slightly assisted the subject leading to greater

19

KEFlowPeak.

Nevertheless, familiarization with the exercise helped to minimize this possibility.

Vascular density may contribute to the observed relationships between the assessments of
endothelial function and flow during knee extension. However, direct assessment of this
parameter was outside the scope of this study. Future studies directly assessing the relationship
between vascular density, PLM, ROV and KEFlow are warranted.
Conclusion
In conclusion, the present study demonstrated that there is a positive, linear correlation
between vascular endothelial function and peak exercise leg blood flow. Subjects that had greater
endothelial function were able to achieve greater flow during the single leg knee extension
exercise. As there are significant differences in leg blood flow at varying work rates between
those of high endothelial function and low endothelial function, it appears that the function of the
endothelium may have an important role in explaining typical variability in submaximal and
peak blood flow observed during exercise (2,3).
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Table 1: Subject Characteristics
Male/Female
Age (yr)

12/7
23 ± 0.57

Height (cm)

172.85 ± 2.04

Weight (kg)

72.8 ± 3.12

BMI (kg·m−2)

24.15 ± 0.62

Knee Extension MVC (kg)

66.9 ± 3.66

KEmax (W)

52.6 ± 4.08

Thigh Mass (kg)

5.08 ± 0.38

Quad Mass (kg)

2.11 ± 0.48

Resting Blood Flow (ml·min−1)
−1
KEFlowPeak (ml·min )
PLMFlowPeak

(ml·min−1)

ROVFlowPeak

(ml·min−1)

FMD (% dilation)

380.1 ± 27.51
4310.47 ± 217.88
1434.6 ± 102.23
1951.45 ± 132.1
6.15 ± 0.64

Values are ± SE
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Table 2: Correlation Between Blood Flow and Vascular Conductance During Knee Extension Exercise and
Vascular Endothelial Function
KEFlowPeak

KEConductancePeak

KEFlow30 Watts

r = 0.72, P = 0.001

r = 0.26, P = 0.30

r = 0.46, P = 0.05

r = 0.63, P = 0.006

Quadriceps Mass (kg)

r = 0.64, P = 0.001

r = 0.51, P = 0.03

r = 0.46, P = 0.05

r = 0.56, P = 0.01

BMI (kg·m−2)

r = 0.72, P = 0.001

r = 0.28, P = 0.27

r = 0.49, P = 0.03

r = 0.64, P = 0.006

Gender (F = 1, M = 2)

r = 0.77, P = 0.001

r = 0.46, P = 0.06

r = 0.56, P = 0.01

r = 0.65, P = 0.004

PLMFlowPeak

r = 0.77, P = 0.001

r = 0.57, P = 0.02

r = 0.47, P = 0.04

r = 0.52, P = 0.03

PLMFlowAUC (ml)

r = 0.72, P = 0.001

r = 0.41, P = 0.10

r = 0.40, P = 0.09

r = 0.29, P = 0.25

PLMConductancePeak
−1
−1

r = 0.71, P = 0.002

r = 0.51, P = 0.04

r = 0.36, P = 0.16

r = 0.42, P = 0.10

PLMConductanceAUC
(ml·mmHg−1)

r = 0.54, P = 0.03

r = 0.25, P = 0.36

r = 0.10, P = 0.72

r = 0.09, P = 0.77

KEPowerPeak

(W)

(ml·min−1)

(ml·min ·mmHg )

KEConductance30 Watts

ROVFlowPeak

(ml·min−1)

r = 0.69, P = 0.001

r = 0.60, P = 0.01

r = 0.67, P = 0.03

r = 0.64, P = 0.005

ROVFlowAUC

(ml)

r = 0.16, P = 0.55

r = 0.31, P = 0.22

r = 0.24, P = 0.35

r = 0.03, P = 0.99

ROVConductancePeak
(ml·min−1·mmHg−1)

r = 0.13, P = 0.62

r = −0.15, P = 0.55

r = 0.21, P = 0.40

r = 0.15, P = 0.57

ROVConductanceAUC
(ml·mmHg−1)

r = 0.21, P = 0.40

r = 0.19, P = 0.46

r = 0.25, P = 0.31

r = 0.11, P = 0.69

r = −0.02, P = 0.86

r = −0.08, P = 0.74

r = −0.12, P = 0.62

r = −0.42, P = 0.09

r = 0.55, P = 0.01

r = 0.48, P = 0.04

r = 0.55, P = 0.01

r = 0.50, P = 0.04

FMD (% dilation)
FMDFlowPeak

(ml·min−1)

KEFlowPeak,

peak blood flow during knee extension exercise;
blood flow during knee extension exercise at 30 W;
KEConductancePeak, peak vascular conductance during knee extension exercise;
KEConductance30, vascular conductance during knee extension at 30 W;
KEPowerPeak, knee extension maximum watts;
BMI, Body mass index;
PLMFlowPeak, peak blood flow during passive leg movement;
PLMFlowAUC, area under the curve for blood flow during passive leg movement;
PLMConductancePeak, peak vascular conductance during passive leg movement;
PLMConductanceAUC, area under the curve for vascular conductance during passive leg movement;
ROVFlowPeak, peak blood flow during rapid onset vasodilation;
ROVFlowAUC, area under the curve for blood flow during rapid onset vasodilation;
ROVConductancePeak, peak vascular conductance during rapid onset vasodilation;
ROVConductanceAUC, area under the curve for vascular conductance during rapid onset vasodilation;
FMD, flow-mediated dilation as a % change;
FMDFlowPeak, peak blood flow during flow-mediated dilation.
KEFlow30,
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Table 3: Correlation Between Blood Flow During Knee Extension Exercise and Vascular
Endothelial Function Normalizing for Quadriceps Mass
KEFlowPeak

KEFlow30 Watts

r = −0.25, P = 0.29

r = −0.33, P = 0.17

BMI (kg·m−2)

r = 0.10, P = 0.69

r = −0.30, P = 0.21

Gender (F = 1, M = 2)

r = 0.13, P = 0.59

r = −0.27, P = 0.26

KEPowerPeak (W)

PLMFlowPeak

(ml·min−1·kg−1)

r = 0.61, P = 0.001

r = 0.32, P = 0.18

PLMFlowAUC

(ml·kg−1)

r = 0.54, P = 0.03

r = 0.18, P = 0.46

r = 0.51, P = 0.05

r = 0.38, P = 0.11

−1
ROVFlowAUC (ml·kg )

r = 0.41, P = 0.08

r = 0.42, P = 0.08

FMD (% dilation·kg−1)

r = 0.45, P = 0.05

r = 0.58, P = 0.01

−1
−1
FMDFlowPeak (ml·min ·kg )

r = 0.24, P = 0.33

r = 0.42, P = 0.07

−1

ROVFlowPeak (ml·min

·kg−1)

Normalizing for quadriceps mass by dividing by mass in kg.
KEFlowPeak, peak blood flow during knee extension exercise;
KEFlow30, blood flow during knee extension exercise at 30 W;
KEPowerPeak, knee extension maximum watts;
BMI, Body mass index;
PLMFlowPeak, peak blood flow during passive leg movement;
PLMFlowAUC, area under the curve for blood flow during passive leg movement;
ROVFlowPeak, peak blood flow during rapid onset vasodilation;
ROVFlowAUC, area under the curve for blood flow during rapid onset vasodilation;
FMD, flow-mediated dilation as a % change;
FMDFlowPeak, peak blood flow during flow-mediated dilation.
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Table 4: Partial Correlation Between Knee Extension Peak Exercise Blood Flow and Various
Indices of Endothelial Function when Controlling for A) Quadriceps Mass and B) Power Output
During Knee Extension
KEFlowPeak

A
PLMFlowPeak

(ml·min−1·kg−1)

r = 0.64, P = 0.004

PLMFlowAUC

(ml·kg−1)

r = 0.62, P = 0.007

ROVFlowPeak

(ml·min−1·kg−1)

r = 0.57, P = 0.01

ROVFlowAUC

(ml·kg−1)

r = 0.37, P = 0.13

FMD (% dilation·kg−1)

r = 0.38, P = 0.12

FMDFlowPeak

r = 0.29, P = 0.25

(ml·min−1·kg−1)

KEFlowPeak

B
PLMFlowPeak

(ml·min−1·W−1)

r = 0.70, P = 0.001

PLMFlowAUC

(ml·W−1)

r = 0.63, P = 0.005

ROVFlowPeak

(ml·min−1·W−1)

r = 0.61, P = 0.005

ROVFlowAUC

(ml·W−1)

r = 0.25, P = 0.32

FMD (% dilation·W−1)

r = 0.10, P = 0.70

FMDFlowPeak

r = 0.36, P = 0.14

(ml·min−1·W−1)

(A) Controlling for quadriceps mass and (B) controlling for power output by dividing by watts.
KEFlowPeak, peak blood flow during knee extension exercise;
PLMFlowPeak, peak blood flow during passive leg movement;
PLMFlowAUC, area under the curve for blood flow during passive leg movement;
ROVFlowPeak, peak blood flow during rapid onset vasodilation;
ROVFlowAUC, area under the curve for blood flow during rapid onset vasodilation;
FMD, flow-mediated dilation as a % change;
FMDFlowPeak, peak blood flow during flow-mediated dilation.
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Table 5: Femoral Artery Blood Flow During Knee Extension in Individuals of Low and High Peak PLM-Induced
Hyperemia in (A) Absolute Values and (B) Normalizing for Quadriceps Mass
Low PLM Responders

High PLM Responders

Gender (M/F)

3/5

8/0*

BMI (kg·m−2)

22.8 ± 0.7

25.8 ± 0.7*

1.9 ± 0.1

2.5 ± 0.2*

A

Quadriceps Mass (kg)
KEPowerPeak

(W)

46.3 ± 5.6

65.0 ± 5.0*

PLMFlowPeak

(ml·min−1)

1031 ± 45

1859 ± 107*

PLMFlowAUC

(ml)

248 ± 50

715 ± 67*

ROVFlowPeak

(ml·min−1)

1798 ± 150

2528 ± 209*

ROVFlowAUC

(ml)

380 ± 36

377 ± 45

7.1 ± 0.9

5.1 ± 1.0

1618 ± 83

1913 ± 231

Low PLM Responders

High PLM Responders

Gender (M/F)

5/3

6/2

BMI (kg·m−2)

24.2 ± 0.9

24.6 ± 1.4

2.3 ± 0.2

2.0 ± 0.1

FMD (% dilation)
FMDFlowPeak (ml·min−1)
B

Quadriceps Mass (kg)
KEPowerPeak

(W·kg−1)

25.5 ± 2.1

26.2 ± 2.8

PLMFlowPeak

(ml·min−1·kg−1)

521 ± 29

835 ± 34*

PLMFlowAUC

(ml·kg−1)

167 ± 24

290 ± 18*

ROVFlowPeak

(ml·min−1·kg−1)

880 ± 72

930 ± 77

ROVFlowAUC

(ml·kg−1)

167 ± 18

152 ± 22

FMD (% dilation·kg−1)

2.2 ± 0.8

3.3 ± 0.3

FMDFlowPeak

797 ± 74

819 ± 54

(ml·min−1·kg−1)

Low/high PLM responders are 8 subjects with lowest/highest peak blood flow during passive leg movement.
BMI, Body mass index;
KEPowerPeak, knee extension maximum watts;
PLMFlowPeak, peak blood flow during passive leg movement;
PLMFlowAUC, area under the curve for blood flow during passive leg movement;
ROVFlowPeak, peak blood flow during rapid onset vasodilation;
ROVFlowAUC, area under the curve for blood flow during rapid onset vasodilation;
FMD, flow-mediated dilation as a % change;
FMDFlowPeak, peak blood flow during flow-mediated dilation.
*P < 0.05 vs Low PLM Responders.
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Figure 1: Average femoral artery blood flow during knee extension exercise (KEFlow) conducted
at 10, 20, 30 W, and 75%, 90%, 100% WRmax.
a: significantly different from resting
b: significantly different from 10 W
c: significantly different from 20 W
d: significantly different from 30 W
e: significantly different from 75% WRmax
f: significantly different from 90% WRmax
g: significantly different from 100% WRmax
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Figure 2: The relationship between different indices of endothelial function and peak blood flow
during knee extension exercise (KEFlowPeak).
A Peak blood flow during passive leg movement (PLMFlowPeak) and KEFlowPeak.
B Peak blood flow during rapid onset vasodilation (ROVFlowPeak) and KEFlowPeak.
C Percent dilation during flow-mediated dilation and KEFlowPeak.
D Mean arterial pressure during knee extension exercise and KEFlowPeak.
E Quadriceps mass and KEFlowPeak. Note that bold lines represent a significant correlation.
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Figure 3: The relationship between different indices of endothelial function and peak blood flow
during knee extension exercise (KEFlowPeak) when normalizing for quadriceps mass.
A Peak blood flow during passive leg movement (PLMFlowPeak) and KEFlowPeak.
B Peak blood flow during rapid onset vasodilation (ROVFlowPeak) and KEFlowPeak.
C Percent dilation during flow-mediated dilation and KEFlowPeak.
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Figure 4: Femoral artery blood flow during knee extension exercise in individuals who had low
and high peak PLM-induced hyperemia.
A Absolute blood flow values
B Normalizing for quadriceps mass. Peak flow was the highest blood flow (ml·min-1) achieved
at highest watts per subject (horizontal error bars)
*P < 0.05 vs Low PLM Responders
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